Background-Atrial fibrillation (AF) affects >30 million individuals worldwide and is associated with an increased risk of stroke, heart failure, and death. AF is highly heritable, yet the genetic basis for the arrhythmia remains incompletely understood. Methods and Results-To identify new AF-related genes, we used a multifaceted approach, combining large-scale genotyping in 2 ethnically distinct populations, cis-eQTL (expression quantitative trait loci) mapping, and functional validation. Four novel loci were identified in individuals of European descent near the genes NEURL (rs12415501; relative risk [RR]=1.18; 95% confidence interval [CI], 1.13-1.23; P=6.5×10 −16 ), GJA1 (rs13216675; RR=1.10; 95% CI, 1.06-1.14; P=2.2×10 −8 ), TBX5 (rs10507248; RR=1.12; 95% CI, 1.08-1.16; P=5.7×10 −11 ), and CAND2 (rs4642101; RR=1.10; 95% CI, 1.06-1.14; P=9.8×10 −9 ). In Japanese, novel loci were identified near NEURL (rs6584555; RR=1.32; 95% CI, 1.26-1.39; P=2.0×10 −25 ) and CUX2 (rs6490029; RR=1.12; 95% CI, 1.08-1.16; P=3.9×10 −9 ). The top singlenucleotide polymorphisms or their proxies were identified as cis-eQTLs for the genes CAND2 (P=2.6×10 −19 ), GJA1 (P=2.66×10 −6 ), and TBX5 (P=1.36×10 −5 ). Knockdown of the zebrafish orthologs of NEURL and CAND2 resulted in prolongation of the atrial action potential duration (17% and 45%, respectively). Conclusions-We have identified 5 novel loci for AF. Our results expand the diversity of genetic pathways implicated in AF and provide novel molecular targets for future biological and pharmacological investigation. (Circulation. 2014;130:1225-1235.) jointly supervised this work The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/
A trial fibrillation (AF) is a common arrhythmia with major public health implications because of its high prevalence, significant morbidity, and considerable associated healthcare costs. 1 Currently, there are nearly 3 million individuals in the United States and >8.8 million individuals in Europe who are affected by AF. With an aging population, the prevalence of AF is expected to increase dramatically. In addition to conventional risk factors, 2 a genetic predisposition has been shown to contribute to AF risk. 3 Over the last several years, numerous AF-associated mutations, candidate genes, and risk loci have been identified; however, much of the heritability of AF remains unexplained.
Clinical Perspective on p 1235
Genome-wide association studies (GWASs) have identified thousands of genetic loci associated with a wide range of conditions and traits. Most studies use a stringent threshold of genome-wide significance that, although minimizing false-positive associations, often fails to identify many disease-associated loci. Increasing the sample size of a GWAS will enhance the power, but for many diseases, large numbers of affected individuals are unavailable, and genotyping remains expensive. Because we have a limited understanding of the pathophysiology of AF, genetic discovery provides an important tool to identify novel pathways and therapeutic targets for the arrhythmia. Given these challenges, we sought to identify AF susceptibility loci using a combination of genotyping, expression quantitative trait loci (eQTL) mapping, and functional validation.
Methods

Overall Study Design
We have used available genome-wide association data sets for AF in Europeans and Japanese and have identified selected genetic variants for additional replication in independent individuals. After separate analyses in each replication cohort, we meta-analyzed the novel findings with the respective prior derivation stages. Variants that reached genome-wide significance for association with AF were subjected to additional analyses. First, we performed eQTL mapping in publicly available domains and left atrial tissue samples to identify gene expression changes depending on the identified genotypes. Second, we applied implicated loci pathway and gene enrichment analyses to better characterize novel candidate genes. Third, we performed candidate gene knockdown in an embryonic zebrafish model to test for morphological and functional changes resulting from gene expression changes. Fourth, we conducted coimmunoprecipitation of candidate genes to inform protein-based interactions of our novel candidate genes. Finally, we looked up our association findings in a large consortial data set of patients with ischemic stroke, a major consequence of AF. The study design, including main results, is summarized in Figure 1 .
Study Samples
Potential novel AF susceptibility signals in Europeans and Japanese were selected from a discovery sample consisting of cohorts with incident and prevalent AF, which has been previously described. 4 To replicate variants from the discovery sample, we recruited additional samples and cohorts with available DNA for direct genotyping or existing GWAS data for in silico analysis. European replication samples included 6691 independent AF cases and 17 144 controls. In Japanese, an additional 1618 AF cases and 17 190 controls were analyzed; in a second replication stage, another 5912 AF cases were added, totaling 8373 AF cases. A detailed description of replication cohorts is available in the Methods section in the online-only Data Supplement. Institutional Review boards or Ethics committees approved each contributing site. All participants provided written informed consent for participation in the cohorts, particularly allowing the analysis of DNA for genetic studies.
Selection of Single Nucleotide Polymorphisms for Replication
To identify single nucleotide polymorphisms (SNPs) for replication analyses in Europeans, we used the meta-analysis data set from the GWAS performed by the AFGen consortium 4 and performed several selection steps: First, we selected all SNPs (n=195) that demonstrated suggestive associations with the arrhythmia as defined by a metaanalysis value of P<5×10 −5 . This significance threshold for SNP inclusion was based on the expected power given an estimated independent validation sample size. Second, we subjected SNPs within 1 Mb of the published genome-wide significant loci to further selection. All SNPs with a linkage disequilibrium measure r 2 ≥0.1 with the published top signals were omitted to avoid the inclusion of SNPs tagging the published results. Third, we selected all SNPs with a minor allele frequency ≥5%. SNPs with a minor allele frequency <5% were included if they were located in exons or the 3′ untranslated region of known genes. Finally, we selected 49 variants. Given the smaller initial sample size of the GWAS in Japanese, a more extensive list of SNPs was considered for replication on the basis of genotyping platform availability and cost. Balancing our statistical power and genotyping considerations, we thus selected the top 500 SNPs at 350 independent loci from a prior meta-analysis for successive rounds of genotyping as described in the Methods section in the online-only Data Supplement. 4
Genotyping
Cohorts of European descent were directly genotyped with the iPlex matrix-assisted laser desorption/ionization time-of-flight mass spectrometry technique based on Sequenom platforms. All genotypes were analyzed by use of dedicated calling software applying the manufacturer's recommendations. In Ottawa, TaqMan assays (Applied Biosystems, Inc, Foster City, CA) were used. For in silico replication cohorts, genotypes from commercially available Affymetrix and Illumina genotyping arrays were used. Each cohort used genotyping results imputed to >2.5 million HapMap SNPs based on the HapMap CEPH (Utah residents with ancestry from northern and western Europe) panel. Cohort-specific details are described in Table I in the online-only Data Supplement. For genotyping in Japanese cases, the multiplex polymerase chain reaction-based Invader Assay (Third Wave Technologies) was used according to the manufacturer's recommendations. Quality control for all genotyping results required a call rate ≥99% in both cases and controls, and deviations from the Hardy-Weinberg equilibrium were accepted to a value of P>1.0×10 −6 in controls.
Statistical Methods in Europeans
For genetic associations, studies from the GWAS discovery stage were calculated as described earlier. 4 In the replication cohorts, we used logistic regression models to assess the associations between SNPs and AF; to achieve higher statistical power in smaller replication cohorts, we combined prevalent and incident AF cases. All models were adjusted for age at DNA draw and sex. Cohorts with multiple study centers were further adjusted for site. Associations derived from GWAS data sets were also adjusted for principal components to account for population structure. Each cohort contributing in silico replicated SNPs used significant principle components specific to their data set. We assumed an additive model of inheritance. Associations were restricted to SNPs selected according to the description above. Directly genotyped SNPs were used following standard genotyping quality control. For imputed SNPs from GWAS cohorts, we used the observed to expected variance of the imputed SNP genotype count (r 2 ) to adjudicate the imputation quality, and we included only SNPs with r 2 ≥0.3 (range, 0-1; 0=random imputation, 1=perfect imputation).
We meta-analyzed study-specific association results using the software Meta-Analysis Helper (METAL), applying a fixed-effects approach weighted for the inverse of variance. Association effects are presented as relative risks (RRs). For significant SNPs, we also computed tests of heterogeneity among the study effects; the P values for the 4 SNPs in Table 1 were all >0.05 and thus not significant. We considered novel loci significantly associated when they exceeded the commonly accepted threshold of genome-wide significance at P=5×10 −8 after meta-analyzing our GWAS discovery cohorts with the replication cohorts. For novel loci, we drew regional association plots using LocusZoom considering up to ±1000 kb around the respective top SNP.
Statistical Methods in Japanese
The associations of all SNPs were assessed with the Cochran-Armitage trend test. To further validate the results of the discovery-stage analysis, we selected the 500 SNPs with the most significant Cochran-Armitage trend P values for follow-up analyses in an additional 1618 Japanese AF cases and 17 190 AF-free controls. Of the selected 500 SNPs, 150 showed evidence of strong linkage disequilibrium with other selected markers as assessed by the Haploview software. We thus selected 350 SNPs for further genotyping. We combined the genotype data of both the first and second stages for meta-analysis using the Mantel-Haenszel method. We also assessed the heterogeneity of our results for all significantly associated SNPs calculating Breslow-Day tests. All tests yielded values of P>0.05 and were thus nonsignificant: rs6584555, P=0.90; rs6490029, P=0.14; rs639652, P=0.46; rs1906599, P=0.77; rs6466579, P=0.27; and rs12932445, P=0.98.
Analysis of eQTLs
We performed eQTL analyses from 2 sources: the Cleveland Clinic Atrial Tissue Bank and the publicly available Genotype-Tissue Expression Portal of the Broad Institute of Harvard and MIT. We first searched for all 49 SNPs considered for replication analysis in Europeans and the 2 SNPs identified in Japanese. Second, for those SNPs exceeding or approaching genome-wide significance after replication (Table 1) , we additionally searched for all proxy SNPs, defined as those with at least moderate linkage disequilibrium (r 2 ≥0.5) with the sentinel SNPs. Detailed methods are provided in the online-only Data Supplement.
Implicated Loci Pathways
We also performed gene enrichment analyses at our implicated loci to determine known functional interactions between the 5 newly discovered loci and the 9 previously reported AF loci, 4 in addition to 6 genes from eQTL analysis. The Web-based tool GRAIL analyzes the connectivity between genetic loci using information retrieved from text mining. 5 Here, we combined 20 loci, including the 14 AF loci and 6 eQTL genes, as both the query and seed regions. The search was performed on abstracts in PubMed published before August 2012. Of the 20 queried loci, 10 showed an excess of connectivity (P GRAIL <0.05 after multiple-testing correction). These loci were connected by key words such as cardiac, heart, channels, atrial, or similar. In addition, we used the Ingenuity Pathway Analysis tool to examine functional enrichment of the 14 AF loci. For each locus, we searched genes within 1 Mb of the top SNP. A total of 275 genes were found. These genes were then analyzed by Ingenuity Pathway Analysis, and the most significant canonical pathways were reported.
Knockdown of Candidate Genes in Zebrafish
Zebrafish of the Tübingen/AB strain were maintained according to standard methods. Morpholino oligonucleotides designed to disrupt the proper splicing or translation of zebrafish genes neurla, cand2, cand1, and cux2b were obtained from Genetools LLC (Corvallis, OR). Measurements of heart rate and contractile function and optical mapping were obtained as previously described. 6 Details are provided in the online-only Data Supplement.
Coimmunoprecipitation in COS7 Cells
For coimmunoprecipitation in COS7 cells, we transfected an expression plasmid of Myc-or FLAG-tagged target genes into COS7 cells (HSRRB; JCRB9127) using Fugene 6 (Roche). At 24 hours after transfection, immunoprecipitations were performed in lysis buffer (20 mmol/L Tris, pH 7.5, with 150 mmol/L NaCl, 0.4% Nonidet P-40 containing 5 μg/mL MG-132 and protease inhibitor tablet EDTA-Roche) using anti-Myc-tagged (Santa Cruz) or anti-FLAG-tagged M2 agarose (Sigma). We visualized targets using horseradish peroxidaseconjugated anti-FLAG (Sigma) or anti-Myc antibodies (Santa Cruz).
Results
Study Design
The overall design of the study is illustrated in Figure 1 . In Europeans, the AFGen discovery sample comprised 16 studies that included 6707 AF cases and 52 426 AF-free controls. 4 There were 195 SNPs with P values between 1×10 −5 and 5×10 −8 in the AFGen discovery sample. On the basis of a priori power calculations, we then selected 49 SNPs that were not in strong linkage disequilibrium with previously identified loci (r 2 <0.1). The SNPs were directly genotyped in 6 studies, and in silico replication was performed in 3 studies, together consisting of 6691 independent AF cases and 17 144 controls (Tables I and II in the online-only Data Supplement). The mean age of the AF cases was 64.2±8.3 years compared with 66.1±7.9 years for controls. Approximately two thirds of cases and half of the controls were male.
After meta-analysis of the replication cohorts with the discovery-stage results from the AFGen Consortium, 4 SNPs exceeded the threshold of genome-wide significance in Europeans; 3 Figure 1 . Flow chart illustrating the study design and major results. Novel chromosomal loci associated with atrial fibrillation (AF) were identified independently in cohorts of European and Japanese descent by means of genome-wide association studies (GWAS) and subsequent replication. Signals in or around NEURL, TBX5, CAND2, GJA1, and CUX2 were detected. Additional studies revealed increased atrial action potential durations after knockdown of NEURL and CAND2 in embryonic zebrafish; an interaction between NEURL and PITX2; an association of GJA1, TBX5, and CUX2 with stroke; and expression quantitative trait loci (eQTL) associations with CAND2, GJA1, TBX5, CEP68, LINC00467, NKX2.5, TMEM116, and WIPF1 in left atrial (LA) and other tissues. APD indicates action potential duration; and SNP, single nucleotide polymorphism. October 7, 2014 further signals were near genome-wide significance (P<5×10 −8 ). Results for the top 4 variants are shown in Table 1 ; full results for all 49 SNPs are provided in Tables III and IV in the onlineonly Data Supplement. Regional association plots for the top 4 associations in Europeans are shown in Figure 2 .
In Japanese, the GWAS discovery sample consisted of 843 AF cases and 3350 AF-free controls. 4 A total of 500 SNPs from 350 loci were genotyped in a replication sample consisting of 1618 AF cases and 17 190 controls, and the results were meta-analyzed with the Japanese GWAS discovery data. Six novel SNPs reaching P<1×10 −7 were genotyped in 5912 additional AF cases of Japanese ancestry, expanding the total number of AF cases to 8373 (Table V in the online-only Data Supplement); 2 SNPs remained significantly associated with AF (Table 1). Regional association plots for the 2 novel variants in Japanese are shown in Figure 2 .
Five Novel AF Risk Loci in Europeans and Japanese
The most significantly associated novel variants in both Europeans and Japanese were intronic to the gene NEURL on chromosome 10q24.33 (Europeans: rs12415501; RR for the AF risk allele, 1.18; 95% confidence interval [CI], 1.13-1.23; P=6.5×10 −16 ; Japanese: rs6584555; RR, 1.32; 95% CI, 1.26-1.39; P=2.0×10 −25 ) . Fine mapping of 10 additional SNPs at the NEURL locus in the Japanese population did not reveal any independent susceptibility signals for AF at this locus (Table VI in the online-only Data Supplement).
The second locus identified in Europeans is intronic to TBX5 on chromosome 12q24 (rs10507248; RR, 1.12; 95% CI, 1.08-1.16; P=5.7×10 −11 ). The third locus identified in Europeans is on chromosome 3p25.2 intronic to CAND2 (rs4642101; RR, 1.10; 95% CI, 1.06-1.14; P=9.8×10 −9 ). The SNP rs4642101 is in moderate to strong linkage disequilibrium (r 2 =0.64) with the nonsynonymous SNP rs2305398 that results in an amino acid substitution from glutamine to arginine (p.Q315R). The fourth locus identified in Europeans is on chromosome 6q22.31 in a large intergenic region (rs13216675; RR, 1.10; 95% CI, 1.06-1.14; P=2.2×10 −8 ). The closest gene is GJA1; rs13216675 is located ≈670 kb downstream of the gene. Interestingly, each of the variants identified in Europeans at TBX5, CAND2, and GJA1 was also associated with AF in Japanese ( Table VII in the online-only Data Supplement). The fifth locus, which was identified only in Japanese individuals, is located intronic to CUX2 (rs6490029; RR, 1.12; 95% CI, 1.08-1.16; P=3.9×10 −9 ) on chromosome 12q24.11-12; we did not observe evidence of an association at the CUX2 locus in Europeans ( Figure I and Table VII in the online-only Data Supplement).
eQTL Loci Mapping
We assessed the influence of novel susceptibility signals on the expression of candidate genes by investigating eQTLs using 2 sources. First, accessing the publicly available Genotype-Tissue Expression Portal, we found several significant associations between gene expression and novel susceptibility loci ( Table VIII in the online-only Data Supplement). The AF risk allele of the top SNP at the CAND2 locus, rs4642101, was significantly associated with a higher expression of CAND2 in skeletal muscle (P=2.6×10 −9 ). A proxy SNP for rs4642101 also had a significant eQTL with CAND2 (rs9877049; P=2.6×10 −19 ; r 2 =0.64). No eQTLs were identified in the Genotype-Tissue Expression Portal database at the 4 other novel loci.
Second, we associated SNP genotypes with gene expression levels in a large repository of left atrial tissue samples (n=289; Table VIII in the online-only Data Supplement). AF was present at the time of tissue acquisition in 136 patients; 70 had no history of AF; and 80 patients were women. Among SNPs at the novel loci for AF, we found significant cis-eQTL associations for which the AF risk allele correlated with a decreased expression of GJA1 (rs13216675; P=9.84×10 −5 ) and the AF risk allele correlated with an increased expression 
3.9×10 −9 *
In both the discovery and replication stages, each cohort provided cohort-specific results, which were subsequently meta-analyzed. In the overall meta-analysis, the summary results of each stage were meta-analyzed, treating each stage as a cohort. In Ottawa, we used rs3825214 as a proxy SNP for rs12415501 (r 2 =0.76). AF indicates atrial fibrillation; CI, confidence interval; GWAS, genome-wide association study; RAF, risk allele frequency; RR, relative risk; and SNP, single-nucleotide polymorphism. *Significant. Among the 49 SNPs initially tested for an association with AF in Europeans, we also observed significant eQTLs for SNPs at 5 other genes. These loci were only marginally associated with AF but exceeded the threshold of significance at P<2.03×10 −4 for eQTL analyses. The respective loci were found for SNPs in or around the candidate genes CEP68, LINC00467, NKX2.5, TMEM116, and WIPF1. In more detail, rs2723065 (association with AF, P=7.6×10 −8 ) and, in particular, rs2540950 (r 2 =0.93 with rs2723065) were strongly associated with the expression of CEP68 (P=9.70×10 −17 ). The 4 other SNPs had a weaker association with AF but a significant cis-eQTL association with the candidate genes LINC00467 (rs12733930; P value for association with AF=8.2×10 −4 ; P value for eQTL=1.59×10 −24 ), NKX2.5 (P for AF=1.0×10 −6 ; P for eQTL=8.78×10 −6 ), TMEM116 (rs6490029; P for , respectively. All regional association plots were prepared with the use of LocusZoom. October 7, 2014 AF=3.9×10 −9 ; P for eQTL=4.28×10 −6 ), and WIPF1 (rs2358891; P for AF=2.0×10 −6 ; P for eQTL=8.87×10 −10 ; Table IV in the online-only Data Supplement).
Zebrafish Knockdown Studies of NEURL, CAND2, and CUX2
For the novel AF risk loci identified in our genetic analyses, we sought to determine the potential role of these genes in cardiovascular function through morpholino-mediated knockdown of orthologs in zebrafish embryos ( Table IX in the online-only Data Supplement). Because TBX5 and GJA1 have well-described roles in cardiovascular physiology, our zebrafish studies focused on the 3 novel candidate genes: NEURL, CAND2, and CUX2.
Zebrafish have a single ortholog of the NEURL and CUX2 genes, neurla and cux2b, but have 2 putative orthologs for the CAND2 gene, cand1 and cand2. We assessed the efficacy and morphological consequences of gene knockdown and the effect on resting heart rate, ventricular contractility, and atrial action potential duration (APD 80 ). Knockdown efficacy was sufficient for all 4 genes ( Table IX in the online-only Data Supplement). Morphologically, embryonic development was only slightly affected by knockdown of neurla and cand1, which showed mild developmental delay, whereas cand2 and cux2b morphants were indistinguishable from controls ( Figure 3A ). There were no significant effects on resting ventricular contractile function ( Figure 3B ) or heart rate ( Figure 3C ) for any knockdowns. We determined the atrial APD 80 by analyzing optical mapping data, as described earlier. 6 For neurla knockdown embryos, the atrial APD 80 was significantly lengthened by 17%, 34%, and 19% for the 3 neurla-targeting morpholinos ( Figure 3D and Table X in the online-only Data Supplement). Knockdown of the zebrafish cand1 gene resulted in a prolongation of the atrial APD 80 by 45% (replication morpholino=31% APD 80 increase) Knockdown of cand2 or cux2b did not significantly alter the APD 80 ( Figure 3D and Table X in the online-only Data Supplement). Representative optical mapping recordings for all 4 gene knockdowns are presented in Figure 3E .
Interaction Between Neurl and Pitx2
NEURL encodes an E3 ubiquitin ligase with a putative RING finger domain. 7 E3 ubiquitin ligases have been shown to interact with several types of transcription factors. 8 Because a number of AF GWAS loci reside at or near transcription factors (PITX2, ZFHX3, PRRX1, TBX5, and CUX2), we tested the direct interaction between NEURL and AF-associated transcription factors. NEURL was coexpressed in COS7 cells with each transcription factor using myc-or FLAG-tagged NEURL and myc-tagged PRRX1, ZFHX3, and TBX5 or FLAG-tagged PITX2 and CUX2. Using coimmunoprecipitation, we demonstrated a NEURL-PITX2 protein interaction ( Figure IIA in the online-only Data Supplement). We did not find evidence of a direct interaction between NEURL and PRRX1, CUX2, or TBX5; studies on ZFHX3 were unsuccessful ( Figure  IIB -IID in the online-only Data Supplement).
Implicated Loci Pathways
To integrate our novel SNP and eQTL findings with the previously described 9 susceptibility loci for AF, 4 we used systems biology-based gene enrichment analyses. With the use of the Web-based tool GRAIL, 10 of the total 20 loci showed an excess of connectivity (P<0.05), involving key words such as cardiac, heart, channels, and atrial ( Figure III in the onlineonly Data Supplement). The most significantly enriched pathways by an Ingenuity analysis were those involving calcium signaling (P=5.3×10 −5 ), L-serine degradation (P=4.1×10 −4 ), and geranylgeranyldiphosphate biosynthesis (P=8.1×10 −4 ).
Relation Between Novel AF Risk Loci and Stroke
AF is strongly associated with an increased risk of stroke. We therefore determined whether the top 5 novel loci from our genetic analyses were associated with ischemic stroke in the METASTROKE collaboration of the International Stroke Genetics Consortium, a meta-analysis of GWAS combining 12 389 ischemic stroke patients and 62 004 controls ( Table 2) . 9 For rs6490029, we detected an association with any type of ischemic stroke (CUX2; odds ratio, 0.95; 95% CI, 0.91-0.98; P=0.0034). Interestingly, the coded allele was hazardous for AF but protective for ischemic stroke. Restricting our analyses to 2365 individuals with cardioembolic stroke, we also found associations for rs13216675 (GJA1; odds ratio, 1.11; 95% CI, 1.04-1.19; P=0.002) and rs10507248 (TBX5; odds ratio, 1.13; 95% CI, 1.05-1.21; P=0.0013). Consistent with findings from the METASTROKE collaboration, different subtypes of stroke show limited overlap in genetic associations. 9
Discussion
In the present study, we sought to integrate multiple parallel techniques to identify novel AF susceptibility loci. Large-scale genotyping in Europeans and Japanese identified novel AF risk loci at or near the genes NEURL, TBX5, CAND2, GJA1, and CUX2. Expression quantitative trait loci mapping in left atrial tissue identified associations between AF SNPs at the CAND2, TBX5, GJA1, CEP68, LINC00467, NKX2.5, TMEM116, and WIPF1 loci. Functional characterization of NEURL and CAND2 orthologs in embryonic zebrafish demonstrated that knockdown of these genes resulted in a significant lengthening of the atrial APD. Furthermore, we found that NEURL and PITX2c physically interacted in a cellular overexpression model. Finally, AF-associated SNPs at the GJA1, TBX5, and CUX2 loci were also significantly associated with ischemic stroke.
The most significantly associated novel AF locus that we identified is intronic to the gene NEURL, which encodes an E3 ubiquitin ligase. NEURL has been reported to be a tumor suppressor gene in malignant astrocytic tumors, and rat and mouse homologs of the gene are highly expressed in muscle tissue. 10 The most consistent cellular abnormalities noted in AF are a calcium overload state and shortening of the atrial APD. 11 Using embryonic zebrafish, we found that knockdown of the NEURL ortholog specifically altered atrial APD without affecting cardiac contractile function or heart rate. Although it is unclear whether the AF-associated SNPs at the locus are associated with an increase or decrease in NEURL expression, our results provide compelling support for the role of NEURL in atrial repolarization and, in turn, AF. 12 In 2007, a genetic locus was described for AF on chromosome 4q25, upstream from the gene encoding the transcription factor PITX2; 13 in the ensuing years, the association between AF and variants at this locus has been widely replicated. Although the role of PITX2 in AF has not yet been fully understood, it is critical for the left-right symmetry of the heart during embryogenesis and the formation of myocardial sleeves in the pulmonary veins. 14 Furthermore, loss of one isoform, PITX2c, has been associated with an increased susceptibility to AF in murine models. Given the in vitro interaction between NEURL and PITX2 that we observed, it is interesting to speculate that NEURL may mediate a susceptibility to AF by ubiquitin-mediated alteration of PITX2 activity.
The second novel locus we identified resides at TBX5, a transcription factor that is critically involved in the development of the cardiac conduction system. 15 We also found that SNPs at this locus modulate the expression of TBX5 in human atrial tissue. Mutations in TBX5 underlie Holt-Oram syndrome, features of which include atrial and ventricular septum secundum defects and conduction abnormalities, including atrioventricular node block. In an atypical form of Holt-Oram syndrome with a high prevalence of AF, a TBX5 gain-of-function mutation was identified, a finding that is consistent with our eQTL results. 16 Two recent GWASs associated the ECG PR interval with variants intronic to or in proximity with TBX5. 17, 18 In the study by Holm et al, 17 the top SNP (rs3825214; r 2 =0.76 with rs10507248) also showed association with AF (P=4.0×10 −5 ) but failed to reach genome-wide significance. In the study by Pfeufer et al, 18 rs1896312 was independent of rs10507248 (r 2 =0) and showed no association with AF (P=0.72). Interestingly, we also found that expression levels of NKX2.5 vary by SNP genotypes in our data set. Together, TBX5 and NKX2.5 are known to play critical roles in both the differentiation of cardiomyocytes and the specialization of conduction and nodal tissue. 15 At the third novel locus, CAND2 encodes a TATA-binding protein, TIP120b, which is muscle specific and critical for myogenesis. 19 We found that the AF-associated SNP at this locus is associated with reduced CAND2/TIP120b expression in striated muscle tissue. Although the specific role of CAND2/TIP120b in AF is currently unclear, we observed atrial action potential prolongation by morpholino-mediated gene knockdown in zebrafish. Additionally, our eQTL analyses indicate that the risk allele is associated with increased expression of CAND2. Extrapolating our findings in zebrafish, increased CAND2 levels would be predicted to shorten the atrial APD, as has been widely observed in AF.
GJA1, a strong candidate gene at our fourth AF locus, encodes the gap junction protein connexin43 on chromosome 6q22.31 which is abundantly expressed in the heart. 20 We found that AF-associated SNPs influenced the transcription of GJA1 in both left atrial tissue and the whole heart. Connexin43, the predominant cardiac gap junction protein, facilitates coordinated electric activity between adjacent myocytes. Germline mutations in GJA1 have been associated with syndromic diseases such as hypoplastic left heart syndrome, atrioventricular canal defects, or oculodentodigital dysplasia. Interestingly, a somatic, loss-offunction mutation in connexin43 has been found to underlie AF in humans. 21 Furthermore, mice with 60% reduced atrial Gja1 expression showed an increased susceptibility to induced AF and atrial tachycardia. 22 Two independent swine models with an AF-induced reduction in GJA1 expression demonstrated that restoration of GJA1 expression ameliorated AF burden. 13 More recently, SNPs in proximity of GJA1 have been reported to be associated with resting heart rate 23 ; however, the AF variants appear to be unrelated to both (r 2 =0.02 for each).
At the fifth locus, CUX2, cut-like homeobox 2, is a transcription factor implicated in cell-cycle progression relevant for spinal cord development 24 and has been investigated for its contribution to bipolar disorder. More recently, the Wellcome Trust Case Control Consortium identified variants at CUX2 as a significant susceptibility marker for type 1 diabetes mellitus. 25 Yet, the reported SNP rs1265564 displays only weak linkage disequilibrium (r 2 =0.17) with the AF SNP rs6490029. In another GWAS of Koreans and Japanese for coronary artery disease, CUX2 was suggested as a susceptibility locus but failed to replicate. 26 The CUX2 association was Japanese specific; we did not find evidence for an association in the region among Europeans ( Figure I in the online-only Data Supplement). The specificity of the CUX2 association in Japanese was in contrast to the other 4 loci that were all associated with AF to various degrees ( Table 1 and Table VII in the online-only Data Supplement). The variability in the association between individuals of European and Japanese ancestry may be due to differences in allele frequency or sample size or to another intrinsic difference between the populations.
Clinically, AF confers a 5-fold increased risk of stroke. We found that the AF SNPs at the CUX2, GJA1, and TBX5 loci were associated with ischemic stroke in the METASTROKE collaboration. Interestingly, we found that the AF risk allele at the CUX2 locus was associated with a decreased risk of ischemic stroke, whereas the AF risk alleles at the 2 other loci conferred an increased risk of cardioembolic stroke. Given that 2 of the strongest associations for stroke are at the PITX2 and ZFHX3 loci for AF, 27, 28 it is possible that the associations we observed at the GJA1 and TBX5 loci are due to occult AF among the stroke cases. At present, it remains unclear why variants at CUX2 would be associated with a decreased risk of ischemic stroke.
Strengths of our work include the investigation of 2 large samples of AF cases in Europeans and Japanese, eQTL analyses in atrial tissue, functional studies supporting the role for NEURL and CAND2 in AF pathophysiology, and the association of 3 of the novel AF loci with stroke. However, our study was also subject to a number of limitations. We studied individuals of European and Japanese ancestry; thus, extrapolation of our findings to other races and ethnicities may be limited. Although AF often occurs in association with other risk factors, we included all individuals with AF to increase both the generalizability and the statistical power of the present analyses. We acknowledge that the NEURL:PITX2 interaction that we observed was in vitro and that further in vivo studies will be necessary. As with other GWASs, the AF-associated SNPs are unlikely to be the causal variants; rather, they are likely to be a marker of disease risk. Although we believe that our eQTL, coimmunoprecipitation, and zebrafish studies were important initial analyses, ultimately, further fine mapping, sequencing, and functional studies will be required to identify the specific role of these genes in the pathogenesis of AF.
Conclusions
Using a combination of genetic associations, eQTL analyses, and functional mapping of novel genes, we have identified 5 susceptibility loci for AF. Functional analyses of NEURL and CAND2 via zebrafish knockdown resulted in alterations in atrial electrophysiology, and protein interaction analysis demonstrated an in vitro interaction between NEURL and PITX2. Finally, our findings indicate that the novel AF signals at GJA1, TBX5, and CUX2 were significantly associated with ischemic stroke or its subtypes. In aggregate, our studies expand our understanding of the molecular pathways and clinical implications of this common and morbid arrhythmia. 
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